Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Discover the journal dedicated to clinical cardiovascular pharmacology.
Every year, the Working Group on Cardiovascular Pharmacotherapy organises a meeting named EuroCVP to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologistswith an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.
Indeed, all cardiologists are concerned by pharmacology and drugs therapy. Consequently, they should all participate and contribute to EuroCVP.
During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.
- Sunday 28 May 2017 (3 Days)
The Working Group on Cardiovascular Pharmacotherapy is delighted to announce the 2016 edition of its Annual Meeting that will be held in Tel Aviv, Israel from 29 to 30 May and aims to highlight key issues in drug therapy.
- Saturday 27 May 2017 (2 Days)
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
- Thursday 22 June 2017 (5 Days)
Organised by the Council on Basic Science: Inspire a new generation of basic cardiovascular science leaders taken from among the most gifted science and medical graduates - Provide opportunities to meet face-to-face role models from an expert faculty of successful cardiovascular scientists.
© 2017 European Society of Cardiology. All rights reserved